| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33084 | |||
| IHC-Prediluted | NBP2-44524 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF1047-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47781-0.1mg | |||
| IHC-Prediluted | NBP2-48351 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB1047-SP | |||
| Carrier Free | IC1047V-100UG | |||
| Carrier Free | IC1047U-100UG | |||
| Carrier Free | IC1047T-100UG | |||
| Carrier Free | IC1047S-100UG | |||
| Carrier Free | IC1047R-100UG | |||
| Carrier Free | IC1047N-100UG | |||
| Carrier Free | IC1047G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47783-0.1mg | |||
| IHC-Prediluted | NBP2-48371 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-08961 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47896-0.1mg | |||
| IHC-Prediluted | NBP2-48383 | |||
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (WA-1) [NBP2-29463] - Formalin-fixed, paraffin-embedded human bladder carcinoma stained with p21 Monoclonal Antibody (WA-1).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-WA-1-Immunohistochemistry-Paraffin-NBP2-29463-img0001.jpg "Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (WA-1) [NBP2-29463] - Formalin-fixed, paraffin-embedded human bladder carcinoma stained with p21 Monoclonal Antibody (WA-1).")
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (DCS-60.2) [NBP2-44525] - Human Bladder Carcinoma stained with p21/CIP1/CDKN1A Antibody (DCS-60.2).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-DCS-60-2-Immunohistochemistry-Paraffin-NBP2-44525-img0006.jpg "Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (DCS-60.2) [NBP2-44525] - Human Bladder Carcinoma stained with p21/CIP1/CDKN1A Antibody (DCS-60.2).")
![Simple Western: p21/CIP1/CDKN1A Antibody (DCS-60.2) [NBP2-44525] - Simple Western lane view shows a specific band for p21/CIP1/CDKN1A in 0.2 mg/ml of MCF-7 lysate(s). This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-DCS-60-2-Simple-Western-NBP2-44525-img0002.jpg)
![Simple Western: p21/CIP1/CDKN1A Antibody (DCS-60.2) [NBP2-44525] - Electropherogram image of the corresponding Simple Western lane. p21/CIP1/CDKN1A antibody was used at 10 ug/ml dilution of MCF-7 lysates(s) respectively.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-DCS-60-2-Simple-Western-NBP2-44525-img0003.jpg)
![Knockout Validated: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Wild-type (WT) and p21 Cip1 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with p21 Cip1 antibody [GT1032]. HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Western-Blot-NBP2-43697-img0005.jpg "<b>Genetic Strategies Validation. </b>Knockout Validated: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Wild-type (WT) and p21 Cip1 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with p21 Cip1 antibody [GT1032]. HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
![<b>Biological Strategies Validation and Genetic Strategies Validation.</b>Western Blot: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Analysis of: A. 30 ug HCT116 whole cell lysate/extract (untreated) B. 30 ug HCT116 whole cell lysate/extract (30 uM Cisplatin treatment for 24 hr) C. 30 ug HCT116 whole cell lysate/extract (30 uM Cisplatin treatment for 48 hr) 15 % SDS-PAGE p21 Cip1 antibody [1032].](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Western-Blot-NBP2-43697-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Sample: Mock and treated HCT116 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: p21 Cip1 stained by p21 Cip1 antibody [1032] diluted at 1:500.Blue: Hoechst 33342 staining. Scale bar= 10 um.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Immunocytochemistry-Immunofluorescence-NBP2-43697-img0010.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Human lung cancer. p21 Cip1 stained by p21 Cip1 antibody [1032] diluted at 1:200.Antigen Retrieval: Citrate buffer, pH 6.0, 15 min.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Immunohistochemistry-Paraffin-NBP2-43697-img0007.jpg)
![Flow Cytometry: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - p21 Cip1 antibody [1032] detects p21 Cip1 by flow cytometry analysis. Sample: HepG2 cell. Black: Unlabelled sample was used as a control. Red: p21 Cip1 antibody [1032] dilution: 1:50. Acquisition of 20,000 events were collected for FACS analysis.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Flow-Cytometry-NBP2-43697-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Analysis of Sample: MCF7 cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: CDK4 protein stained by CDK4 antibody diluted at 1:1000. Red: p21 Cip1 protein stained by p21 Cip1 antibody [1032] diluted at 1:500. Blue: Hoechst 33342 staining.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Immunocytochemistry-Immunofluorescence-NBP2-43697-img0004.jpg)
![<b>Biological Strategies Validation. </b>Immunoprecipitation: p21/CIP1/CDKN1A Antibody (1032) [NBP2-43697] - Analysis of HCT-116 whole cell extract treat with 30uM cisplatin for 48 hr A. 30 ug HCT-116 whole cell extract treat with 30uM cisplatin for 48 hr B. Control with 4 ug of preimmune Mouse IgG C. Immunoprecipitation of CDKN1A protein by 4 ug p21 Cip1 antibody [1032] 15 % SDS-PAGE The immunoprecipitated CDKN1A protein was detected by p21 Cip1 antibody [1032] diluted at 1:1000. [EasyBlot anti-mouse IgG was used as a secondary reagent]](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1032-Immunoprecipitation-NBP2-43697-img0002.jpg)
![Western Blot: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Analysis of extracts of various cell lines, using p21/CIP1/CDKN1A antibody (NBP3-15661) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 3min.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Western-Blot-NBP3-15661-img0010.jpg "Western Blot: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Analysis of extracts of various cell lines, using p21/CIP1/CDKN1A antibody (NBP3-15661) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Enhanced Kit. Exposure time: 3min.")
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Human liver cancer using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0009.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Human esophageal cancer using p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0002.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Human colon carcinoma using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0003.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Human liver cancer using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0004.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Mouse liver using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0005.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Rat liver using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0006.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Rat ovary using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0007.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (1L4J1) [NBP3-15661] - Human esophageal cancer using [KO Validated] p21/CIP1/CDKN1A Rabbit mAb (NBP3-15661) at dilution of 1:100 (40x lens).Perform high pressure antigen retrieval with 10 mM citrate buffer pH 6.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-1L4J1-Immunohistochemistry-Paraffin-NBP3-15661-img0008.jpg)
![Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/823) [NBP2-44527] - Analysis of human HeLa cell lysate using p21/CIP1/CDKN1A Antibody (CIP1/823).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-Western-Blot-NBP2-44527-img0003.jpg "Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/823) [NBP2-44527] - Analysis of human HeLa cell lysate using p21/CIP1/CDKN1A Antibody (CIP1/823).")
![Immunocytochemistry/Immunofluorescence: p21/CIP1/CDKN1A Antibody (CIP1/823) [NBP2-44527] - Analysis of HeLa cells labeling p21 with p21/CIP1/CDKN1A Antibody (CIP1/823) followed by Goat anti-Mouse IgG-CF555 (Red). Membrane stained with Phalloidin 488 (Green).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-Immunocytochemistry-Immunofluorescence-NBP2-44527-img0004.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/823) [NBP2-44527] - Human Lung Squamous Cell Carcinoma (SCC) stained with p21 Monoclonal Antibody (CIP1/823).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-Immunohistochemistry-Paraffin-NBP2-44527-img0002.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/823) [NBP2-44527] - Human Bladder Carcinoma stained with p21 Monoclonal Antibody (CIP1/823).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-Immunohistochemistry-Paraffin-NBP2-44527-img0001.jpg)
![Knockout Validated: p21/CIP1/CDKN1A Antibody [NBP2-19652] - Wild-type (WT) and p21 Cip1 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with p21 Cip1 antibody. HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-Western-Blot-NBP2-19652-img0008.jpg "<b>Genetic Strategies Validation. </b>Knockout Validated: p21/CIP1/CDKN1A Antibody [NBP2-19652] - Wild-type (WT) and p21 Cip1 knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with p21 Cip1 antibody. HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
![<b>Biological Strategies Validation and Genetic Strategies Validation.</b>Western Blot: p21/CIP1/CDKN1A Antibody [NBP2-19652] - Sample (30 ug of whole cell lysate) A: HCT116 cells with 30uM cisplatin treatment for 0hr B: HCT116 cells with 30uM cisplatin treatment for 24hr 12% SDS PAGE gel.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-Western-Blot-NBP2-19652-img0006.jpg)
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: p21/CIP1/CDKN1A Antibody [NBP2-19652] - HeLa cells mock (left) and treated with 30 uM Cisplatin for 24 hrs (right) were fixed in 4% paraformaldehyde at RT for 15 min. Green: p21 Cip1 protein stained by p21 Cip1 antibody. Blue: Hoechst 33342 staining.Scale bar = 10 um.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-19652-img0005.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody [NBP2-19652] - SkHep1xenograft. p21 Cip1 antibody dilution: 1:500. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-Immunohistochemistry-Paraffin-NBP2-19652-img0002.jpg)
![Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - Western Blot Analysis of HeLa cell lysate using p21/CIP1/CDKN1A antibody (CIP1/4377R).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-4377R-Western-Blot-NBP3-07215-img0005.jpg "Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - Western Blot Analysis of HeLa cell lysate using p21/CIP1/CDKN1A antibody (CIP1/4377R).")
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - Formalin fixed paraffin embedded human lung carcinoma stained with p21/CIP1/CDKN1A Rabbit Recombinant Monoclonal Antibody (CIP1/4377R).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-4377R-Immunohistochemistry-Paraffin-NBP3-07215-img0004.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - Formalin fixed paraffin embedded human colon carcinoma stained withp21/CIP1/CDKN1A Rabbit Recombinant Monoclonal Antibody (CIP1/4377R).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-4377R-Immunohistochemistry-Paraffin-NBP3-07215-img0002.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - IHC analysis of formalin-fixed, paraffin-embedded human brain. Negative tissue control using p21/CIP1/CDKN1A antibody (CIP1/4377R) at 2ug/ml in PBS for 30min RT. HIER: Tris/EDTA, pH9.0, 45min. 2 : HRP-polymer, 30min. DAB, 5min.](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-4377R-Immunohistochemistry-Paraffin-NBP3-07215-img0003.jpg)
![Protein Array: p21/CIP1/CDKN1A Antibody (CIP1/4377R) [NBP3-07215] - Analysis of Protein Array containing more than 19,000 full-length human proteins using p21/CIP1/CDKN1A Antibody (CIP1/4377R).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-4377R-Protein-Array-NBP3-07215-img0006.jpg)
![ELISA p21/CIP1/CDKN1A [Biotin]](http://images.novusbio.com/fullsize2/dyc1047-2_human-total-p21-cip1-cdkn1a-duoset-ic-elisa-2-plate-elisa-1592020122156.jpg "ELISA p21/CIP1/CDKN1A [Biotin]")
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (HJ21) [NBP2-44528] - Bladder Carcinoma stained with p21 Monoclonal Antibody (HJ21).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-HJ21-Immunohistochemistry-Paraffin-NBP2-44528-img0001.jpg "Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (HJ21) [NBP2-44528] - Bladder Carcinoma stained with p21 Monoclonal Antibody (HJ21).")